Patent Assignment
Reel/Frame 017636/0360
Change of Name
Recorded: 2006-05-18
Pages: 5
Assignor
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Executed: 2001-12-31
Assignee
AVENTIS PHARMACEUTICALS INC.
300 SOMERSET CORPORATE BLVD., BRIDGEWATER, NEW JERSEY, 08807-2854
Covered Properties
(37)
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent:
4,920,132 →
Application:
07/116,420 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent:
4,920,133 →
Application:
07/116,428 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent:
4,920,130 →
Application:
07/116,597 →
Quinolinyl Ether or Thioether Tetrazoles as Agents for the Treatment of Hypersensitive Ailments
Patent:
4,874,769 →
Application:
07/124,800 →
Method for the Preparation of a Theophylline Sustained Release Pharmaceutical Composition and the Composition Prepared Thereby
Patent:
5,026,709 →
Application:
07/203,435 →
Product-Dispensing Method and Apparatus
Patent:
4,876,891 →
Application:
07/203,566 →
Quinoline Derivatives and Use Thereof as Antagonists of Leukotriene D4
Patent:
4,920,131 →
Application:
07/209,428 →
Intranasal Calcitonin Formulations
Patent:
5,026,825 →
Application:
07/242,000 →
Quinoline Derivatives and Their Use as Antagonists of Leukotriene D4
Patent:
5,059,610 →
Application:
07/477,896 →
Quinoline Derivatives as Antagonists of Leukotriene D4
Patent:
5,028,615 →
Application:
07/499,513 →
Binding Theophylline to Ion Exchange Resins
Patent:
5,162,110 →
Application:
07/629,833 →
Product-Dispensing Method and Apparatus
Patent:
5,125,466 →
Application:
07/649,304 →
Quinoline Derivatives as Antagonists of Leukotriene D4
Patent:
5,166,210 →
Application:
07/724,745 →
Pluripotential Quiescent Stem Cell Population
Patent:
5,807,686 →
Application:
08/482,318 →
Bis Mono-and Bicyclic Aryl and Heteroaryl Compounds Which Inhibit Egf and/or Pdgf Receptor Tyrosine Kinase
Patent:
6,057,320 →
Application:
08/881,991 →
Process for the Solid Phase Synthesis of Aldehyde Ketone Oxime Amine Hydroxamic Acid and a -B-Unsaturated Carboxylic Acid and Aldehyde Compounds
Patent:
6,133,409 →
Application:
09/103,872 →
Process for Preparing 2,4- Dihydroxypyridine and 2,4- Dihydroxy-3-Nitropyridine
Patent:
6,307,054 →
Application:
09/108,622 →
Pharmaceutical Composition Comprising a Compound Having Anti-Xa Activity and a Platelet Aggregation Antagonist Compound
Patent:
6,103,705 →
Application:
09/192,710 →
Quinoline and Quinoxaline Compounds Which Inhibit Platelet-Derived Growth Factor and/or P56LCK Tyrosine Kinases
Patent:
6,180,632 →
Application:
09/198,718 →
Quinoline and Quinoxaline Compounds Which Inhibit Platelet-Derived Growth Factor and/or P56LCK Tyrosine Kinases
Patent:
6,245,760 →
Application:
09/198,720 →
Piperididinyl and N-Amidinopiperidinyl Derivatives
Patent:
6,277,865 →
Application:
09/273,618 →
Functionalized Resin for the Synthesis of Amides and Peptides
Patent:
6,127,515 →
Application:
09/316,671 →
Elastomer Treatment Process to Decrease Peroxide Levels
Patent:
6,248,841 →
Application:
09/355,693 →
Substituted Beta-Thiocarboxylic Acids
Patent:
6,306,873 →
Application:
09/357,734 →
Luciferase Reporter Bioassay of Parathyroid Hormone Compounds
Patent:
6,720,153 →
Application:
09/387,176 →
Process for the Solid Phase Synthesis of Aldehyde, Ketone, Oxime, Amine, Hydroxamic Acid and a,B-Unsaturated Carboxylic Acid and Aldehyde Compounds
Patent:
6,392,010 →
Application:
09/469,829 →
Process For Preparing N6-Substituted Adenosine Derivatives
Patent:
6,184,382 →
Application:
09/481,979 →
Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
Patent:
6,180,759 →
Application:
09/544,680 →
Aqueous-based pharmaceutical composition
Patent:
6,375,984 →
Application:
09/561,371 →
Nuclear Factor Kappab Inducing Factor
Variants of TRAF2 Which Act as an Inhibitor of Tnf-Alpha (Tnfalpha) Signaling Pathway
Patent:
6,998,475 →
Application:
10/018,030 →
Llg Polypeptides of the Triacylglycerol Lipase Family, and Compositions and Methods for Their Use in Enzymatic Hydrolysis, and Protein and Gene Therapies
Quinoline and Quinoxaline Compounds Which Inhibit Platelet-Derived Growth Factor and/or P56LCK Tyrosine Kinases
Osteopontin, oligodendrocytes and myelination
Application:
10/602,927 →
Publication:
US 2004/0033226
Substituted Oxoazaheterocyclyl Compounds
Variants of TRAF2 Which Act as an Inhibitor of Tnf-Alpha (Tnfalpha) Signaling Pathway
Nuclear Factor Kappab Inducing Factor
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Oct 4, 2001
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 012036/0167 →
Change of Name
Oct 8, 2001
From: RORER PHARMACEUTICAL CORPORATION
To: RHONE-POULENC RORER PHARMACEUTICALS INC.
Reel/Frame 012036/0745 →
Certificate of Conversion
Dec 9, 2014
From: AVENTISUB INC.
To: AVENTISUB LLC
Reel/Frame 034566/0976 →
Merger
Jan 19, 2015
From: AVENTIS PHARMACEUTICALS INC.
To: AVENTISUB LLC
Reel/Frame 034781/0334 →